{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-008131","form_type":"8-K","ticker":"AEMD","cik":"0000882291","company_name":"AETHLON MEDICAL INC","filed_at":"2023-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.232518+00:00","generated_at":"2026-06-08T04:24:07.406751+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Aethlon Medical reports Q2 net loss down to $3.0M; CEO Fisher replaced by Frakes","bullets":["Net loss for fiscal Q2 2023: $3.0M vs $3.8M in prior year; operating expenses decreased 13.4% to $3.2M.","Cash balance $10.2M as of Sept 30, 2023.","CEO Charles Fisher replaced by James Frakes (Interim CEO, retains CFO role); Guy Cipriani becomes COO.","Received DCGI clearance in India for Phase 1 Hemopurifier trial in solid tumors on anti-PD-1 therapy.","Hemopurifier supply disruption continues; working with FDA for second GNA supplier; new San Diego facility."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-008131","json":"https://secwatch.observer/filing/0001683168-23-008131.json","markdown":"https://secwatch.observer/filing/0001683168-23-008131.md","text":"https://secwatch.observer/filing/0001683168-23-008131.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/882291/000168316823008131/0001683168-23-008131-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/882291/000168316823008131/aethlon_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T04:24:07.406751+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ab5d585e5a215d923827e039a9b4567853c586e8","claim":"AETHLON MEDICAL INC reported financial results for fiscal second quarter ended September 30, 2023.","evidence_excerpt":"On November 14, 2023, Aethlon Medical, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/882291/000168316823008131/0001683168-23-008131-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal second quarter ended September 30, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}